Florida Medicaid and Gender-Affirming Care for Minors: Why Coverage Was Stopped
Updated: Aug 16
Florida Medicaid has taken a firm position against using Medicaid funds to pay for gender-affirming medical treatment for minors. The policy excludes puberty blockers, hormone therapy and sex-reassignment surgeries when they are provided to treat gender dysphoria.
The decision has become one of the most controversial healthcare policies in Florida, involving questions about medical evidence, parental rights, government authority, Medicaid coverage and the appropriate treatment of transgender children and adolescents.
For Florida families who rely on Medicaid, understanding what changed—and why—is important.
How Florida Medicaid Changed Its Coverage
Florida's policy dates back to 2022. The Florida Agency for Health Care Administration (AHCA), which administers the state's Medicaid program, reviewed treatments for gender dysphoria after the Florida Department of Health issued guidance concerning gender dysphoria in children and adolescents.
AHCA concluded that puberty blockers, cross-sex hormones and sex-reassignment surgery did not meet Florida's definition of medically necessary treatment for gender dysphoria. The agency characterized the evidence supporting these treatments as weak and classified the services as experimental and investigational.
That determination was incorporated into Florida Medicaid policy. Under Rule 59G-1.050, Florida Medicaid does not cover puberty blockers, hormones or hormone antagonists, sex-reassignment surgeries, or other procedures intended to alter primary or secondary sexual characteristics when used to treat gender dysphoria. The rule also states that these services do not meet the state's definition of medical necessity, including under the federal Early and Periodic Screening, Diagnostic and Treatment program for children.
This distinction is important because the issue is not simply whether a particular doctor believes treatment is appropriate. Florida Medicaid's coverage rules determine whether the Medicaid program will pay for the service.
Ban on gender-affirming care already causing harm, families say, Jacksonville Florida
Why Did Florida Make This Decision?
Florida's explanation centers primarily on medical evidence. AHCA's review argued that the available research did not provide sufficient evidence demonstrating the long-term safety and effectiveness of puberty blockers, hormone therapy and surgery for treating gender dysphoria in children and adolescents. The agency cited the lack of randomized controlled trials and limited long-term follow-up data as important concerns.
Florida officials therefore concluded that Medicaid should not finance treatments they considered insufficiently supported by evidence.
The state also relied on a broader argument: medical decisions involving minors should receive a higher level of caution because children and adolescents are still developing physically and psychologically.
Critics of Florida's policy have strongly disputed that reasoning. They argue that gender-affirming care can be medically appropriate for carefully evaluated patients and that denying treatment can also create significant health consequences. The disagreement illustrates why this issue has become both a medical and legal controversy.
Why Florida Medicaid Stopped Covering Gender Affirming Surgeries
What Treatments Are Affected?
The Florida Medicaid exclusion is broader than surgery alone.
The policy includes several categories of treatment:
Puberty blockers: Medications intended to delay or suppress puberty.
Hormone therapy: Hormones such as estrogen or testosterone used to produce physical characteristics associated with the patient's gender identity.
Sex-reassignment surgery: Surgical procedures intended to alter sexual characteristics.
Other procedures: Florida's Medicaid rule also excludes other procedures that alter primary or secondary sexual characteristics when used for the treatment of gender dysphoria.
It is important not to assume that every prescription for hormones is automatically excluded. The policy concerns treatment for gender dysphoria. Hormones can be prescribed for numerous other medical conditions, and coverage depends on the medical diagnosis, purpose of treatment and applicable Medicaid rules.
The Policy Is Part of a Larger Florida Law
Florida's Medicaid policy does not exist in isolation. In 2023, Florida enacted legislation restricting gender-affirming medical care for minors. The law prohibited certain treatments for minors, including puberty blockers and hormones when used to affirm a person's gender identity when it differs from their sex at birth.
The law also addressed surgical procedures and imposed additional requirements on healthcare professionals.
As a result, Florida's approach involves both Medicaid coverage restrictions and state regulation of medical providers.
Those are separate issues.
A treatment can be medically available in another state while simultaneously being excluded from Florida Medicaid. Likewise, a Medicaid coverage rule determines whether Medicaid will pay for a service; it does not necessarily answer every question about whether a treatment is medically appropriate in every circumstance.
The Policy Has Faced Major Legal Challenges
Florida's position has been challenged in federal court.
One important case is Dekker v. Weida, which challenged Florida Medicaid's exclusion of gender-affirming treatment. The plaintiffs argued that the Medicaid policy violated constitutional protections and federal Medicaid and nondiscrimination requirements.
The litigation produced significant disagreement between federal courts and Florida officials over whether the state's exclusion could lawfully remain in effect.
Separately, Doe v. Ladapo challenged Florida's restrictions on gender-affirming medical treatment for minors. In 2024, a federal district court ruled that significant portions of Florida's restrictions on gender-affirming care for minors were unconstitutional and issued classwide relief concerning puberty blockers and cross-sex hormones.
However, these cases involve different legal questions and should not be treated as if one court decision automatically eliminates every Florida Medicaid coverage restriction.
That distinction matters for families trying to determine whether a particular service is currently covered.
Why the Issue Is So Controversial
There are essentially two competing approaches.
Florida officials have emphasized uncertainty surrounding the long-term evidence and argued that the state should protect minors from treatments they consider insufficiently established.
Opponents argue that the state has improperly substituted government policy for individualized medical decision-making. They maintain that treatment should be determined by qualified healthcare professionals, parents and patients based on individual circumstances.
The legal disputes therefore extend beyond the medical question.
They also involve constitutional rights, federal Medicaid requirements, equal protection, parental decision-making and the authority of states to regulate medical care.
What Does This Mean for a Florida Medicaid Family?
For a Florida family with a minor receiving Medicaid, the practical issue is whether a particular service will be paid for by Medicaid.
Families should not assume that a denial automatically means the child has been found ineligible for Medicaid.
Medicaid eligibility and treatment coverage are different issues.
A child can remain fully eligible for Florida Medicaid while a particular service is excluded from Medicaid coverage.
Families should also carefully examine any written denial received from their managed care plan or Medicaid. The reason for a denial can matter considerably. A denial could involve an excluded service, medical necessity, prior authorization, provider requirements or another coverage rule.
If a family believes Medicaid improperly denied a covered service, it may have appeal rights. The appeal process can depend on whether the decision came from the Medicaid managed care plan, AHCA or another entity.
Parents should keep copies of the denial notice, medical records, authorization requests and communications with the health plan.
A Changing Legal and Medical Landscape
One reason this subject is particularly difficult is that both the medical debate and the legal landscape continue to evolve.
Florida's original Medicaid policy was based on the state's 2022 review, which concluded that the evidence supporting gender-affirming treatments for gender dysphoria was inadequate for Medicaid coverage.
At the same time, federal litigation has challenged Florida's restrictions, producing court decisions that have questioned portions of the state's approach.
Consequently, information published several years ago may not accurately describe the legal status of a treatment today.
Families should verify the current Medicaid policy and the status of relevant court orders before making decisions about treatment or assuming that a particular service is covered or excluded.
What Florida Medicaid Recipients Should Do
Parents or guardians who receive a denial involving gender dysphoria treatment should first read the entire notice carefully.
Look for:
The specific treatment that was denied
The reason for the denial
Whether the denial concerns medical necessity or an excluded service
The effective date
Appeal or grievance instructions
The deadline for requesting an appeal
Instructions for obtaining additional medical records or documentation
Do not ignore the deadline on the notice.
A family can also speak with the child's healthcare providers about alternative medically appropriate treatment and ask the provider to explain the clinical reasoning behind the recommendation.
For Medicaid-specific questions, families should verify information directly with their managed care plan or Florida Medicaid because coverage policies and legal requirements can change.
Related Article
Florida bans Medicaid from covering gender-affirming treatments
The move by the Florida Agency for Health Care Administration came after the agency published a report claiming there was not enough scientific evidence to prove that the treatments improved health. Read full article.
The Bottom Line
Florida Medicaid's decision to exclude gender-affirming treatment for gender dysphoria was driven by the state's determination that the evidence supporting puberty blockers, hormone therapy and sex-reassignment surgery for this purpose was insufficient to establish medical necessity under Florida Medicaid rules. The policy took effect in 2022 and became part of a broader set of Florida restrictions involving gender-affirming care for minors.
The policy has subsequently become the subject of major federal litigation. Courts have disagreed with Florida officials on important aspects of the state's restrictions, making this an area where the legal situation can change.
For Florida Medicaid families, the most important distinction is between Medicaid eligibility and coverage of a particular treatment. A child can remain eligible for Medicaid even when a specific treatment is not covered.
Because this issue involves both healthcare and ongoing litigation, families should rely on the most current Medicaid notices, plan information and court decisions rather than assuming that an older article accurately reflects today's rules.
For Florida Medicaid recipients looking for additional Medicaid information and explanations, Ask Medicaid Florida can provide another Florida-focused resource.
Disclaimer
This website is for informational purposes only. Read full disclaimer.
Comments